Povidone Iodine Gel Swabstick Gel
NDC Package 67777-418-01
Package Information
Povidone Iodine Gel Swabstick gel is • Tear at notch • Remove applicator • Use only onceAs a first aid antiseptic:• Clean affected area• Apply 1 to 3 times daily• May be covered with a sterile bandage• If bandaged, let dry firstFor preoperative patient skin preparation:• Clean area• Apply to operative site prior to surgeryFor Venipuncture skin preparation:• Hold the swabstick at an angle and begin scrubbing in a circular motion over a 1-inch area, directly over the venipuncture site. This formulation utilizes a gel delivery system. Marketed by Dynarex Corporation, this product is identified by NDC 67777-418 and is authorized under FDA application M003.
Identification & Billing
- RxCUI: 312562 - povidone-iodine 10 % Topical Gel
- RxCUI: 312562 - povidone-iodine 0.1 MG/MG Topical Gel
- RxCUI: 312562 - povidone-iodine 10 % (titratable iodine 1 % ) Topical Gel
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 67777 - Dynarex Corporation
- 67777-418 - Povidone Iodine Gel Swabstick
- 67777-418-01 - 10 BOX in 1 CASE / 50 PACKET in 1 BOX (67777-418-02) / .3 mL in 1 PACKET
- 67777-418 - Povidone Iodine Gel Swabstick
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 67777-418-01 identifies a specific commercial package of 10 box in 1 case / 50 packet in 1 box (67777-418-02) / .3 ml in 1 packet of Povidone Iodine Gel Swabstick, a human over the counter drug labeled by Dynarex Corporation. This gel is formulated for topical use and contains povidone-iodine as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Dynarex Corporation on November 25, 2022. The current certification is valid through December 31, 2026.
How is this Dynarex Corporation product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 67777041801. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.